From First-in-Human Studies to Clinical Validation: Advancing Non- Degrading Molecular Glues into Patients
3:30 pm - Wednesday 27th January 2027
- Advancing a novel non-degrading molecular glue from discovery through clinical development, demonstrating how induced-proximity therapeutics can generate therapeutic benefit beyond protein degradation
- Evaluating safety, pharmacokinetics, pharmacodynamic biomarkers, and early signals of activity from first-in-human studies to establish the clinical potential of nondegrading molecular glue therapies
- Sharing key translational and clinical learnings from programme progression to help de-risk future molecular glue development efforts and accelerate the path from innovative biology to patient impact